FIBROSIS: STATUS OF PHASE II AND III CLINICAL TRIALS FOR SKIN AND LUNG IN SYSTEMIC SCLEROSIS

被引：0
|
作者：
Denton, Christopher P. [1 ]
机构：
[1] UCL, Ctr Rheumatol, London, England
来源：
RHEUMATOLOGY | 2019年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
I114
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Immunotherapies in phase II and III trials for the treatment of systemic lupus erythematosus
    Radin, Massimo
    Cecchi, Irene
    Schreiber, Karen
    Baldovino, Simone
    Rossi, Daniela
    Menegatti, Elisa
    Roccatello, Dario
    Sciascia, Savino
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (01): : 55 - 69
  • [22] Empowering phase II clinical trials to reduce phase III failures
    De Martini, Daniele
    PHARMACEUTICAL STATISTICS, 2020, 19 (03) : 178 - 186
  • [23] pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis
    Kafaja, Suzanne
    Valera, Isela
    Divekar, Anagha A.
    Saggar, Rajan
    Abtin, Fereidoun
    Furst, Daniel E.
    Khanna, Dinesh
    Singh, Ram Raj
    JCI INSIGHT, 2018, 3 (09)
  • [24] IL-21 drives skin and lung inflammation and fibrosis in a model for systemic sclerosis
    Um, In Gyu
    Woo, Jin Seok
    Lee, Young Joon
    Lee, Seon-Yeong
    Jeong, Ha Yeon
    Na, Hun Sik
    Lee, Jeong Su
    Lee, A. Ram
    Park, Sung-Hwan
    Cho, Mi-La
    IMMUNOLOGY LETTERS, 2024, 270
  • [25] Relaxin clinical trials in systemic sclerosis
    Erikson, MS
    Unemori, EN
    RELAXIN 2000, 2001, : 373 - 381
  • [26] Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
    Bernard M. J. Uitdehaag
    CNS Drugs, 2018, 32 : 543 - 558
  • [27] Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
    Uitdehaag, Bernard M. J.
    CNS DRUGS, 2018, 32 (06) : 543 - 558
  • [28] MECHANOTRANSDUCTION VIA MYOSIN II ISOFORMS IN DEVELOPMENT OF SKIN FIBROSIS WITHIN SYSTEMIC SCLEROSIS
    Russo, B.
    Shutova, M.
    Romanescu, G.
    Brembilla, N.
    Boehncke, W. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1257 - 1257
  • [29] The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis
    Thachil, Jecko
    MEDICAL HYPOTHESES, 2009, 72 (03) : 291 - 293
  • [30] Quetiapine: Results of four phase II and III clinical trials
    King, DJ
    EUROPEAN PSYCHIATRY, 1998, 13 : 15S - 21S
12345